Measurement of prostate-specific membrane antigen in the serum with a new antibody

Prostate

Volumn 28, Issue 4, 1996, Pages 266-271

  Murphy, G P ^a,c   Tino, W T ^a   Holmes, E H ^a   Boynton, A L ^a   Erickson, S J ^a   Bowes, V A ^a   Barren, R J ^a   Tjoa, B A ^a   Misrock, S L ^b   Ragde, H ^a   Kenny, G M ^a  

^a NORTHWEST HOSPITAL   (United States)

^b Pennie and Edmonds   (United States)

^c NONE   (United States)

Author keywords

prostate cancer; prostate marker; prostate specific membrane antigen (PSMA)

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; HUMANS; HYBRIDOMAS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; PRECIPITIN TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; TUMOR CELLS, CULTURED;

EID: 15844423626     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199604)28:4<266::AID-PROS7>3.0.CO;2-B     Document Type: Article

References (12)

1. Rochon YP, Horoszewicz JC, Boynton AL, Holmes EH, Barren RJ, Erickson SJ, Kenny GM, Murphy GP: Western blot assay for prostate specific membrane antigen in serum of prostate cancer patients. Prostate 25:219-223, 1994.
2. Murphy GP, Holmes EH, Boynton AL, Kenny GM, Ostenson RC, Erickson SJ, Barren RJ: A comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP based Elisa assays in prostatic cancer patients and patients with benign prostatic enlargement. Prostate 26:164-168, 1995.
3. Horoszewicz JS, Kawinski E, Murphy GP: Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7:927-936, 1987
4. Murphy GP, Ragde H, Kenny G, Barren R, Erickson S, Tjoa B, Boynton A, Holmes E, Gilbaugh J, Douglas T: Comparison of prostate specific membrane antigen, .and prostate specific antigen levels in prostatic cancer patients. Anticancer Res 15:1473-1480, 1995.
5. Troyer JK, Feng Q, Beckett ML, Wright GL: Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol Oncol 1:29-37, 1995.
6. Troyer JK, Beckett ML, Wright GL: Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids, Int J Cancer 62:552-558, 1995.
7. Galfré G, Milstein C: Methods in enzymology. In Langove JJ, VanVunakis H (eds): "Immunochemical Techniques." Part B. San Diego: Academic Press, 1981, pp 3-47.
8. Pelletier DB, Boynton A: Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication. J Cellular Physiology 158:427-434, 1994.
9. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD: Expression of the prostate-specific membrane antigen. Cancer Res 54:1807-1811, 1994.
10. Su SL, Huang IP, Fair WR, Powell CT, H, Heston WD: Alternatively spliced variants of prostate-specific membrane antigen RNA; ratio of expression as a potential measurement of progression. Cancer Res 55:1441-1443, 1995.
11. Hopp TP, Woods KR: A computer program for predicting protein antigenic determinants. Mol Immunol 20:483-489, 1983.
12. Carter RE, Feldman AR, Coyle JT: Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad SCI USA 93:749-753, 1996.